Skip to main content
. 2014 Oct 28;9(10):e110476. doi: 10.1371/journal.pone.0110476

Table 3. Summary of the health-related quality of life parameters overtime (baseline and 12 months) – Intention-to-treat analysis.

Intervention (n = 93) Placebo (n = 99) Mean difference(95% CI) betweentreatment groupa
Mean (95% CI) Mean (95% CI)
Physical functioning
Baseline 74.68 (70.81 to 78.84) 70.96 (66.13 to 75.79) 3.718 (–2.624 to 10.06)
12 months 71.81 (66.53 to 77.09) 71.48 (66.62 to 76.33) 0.330 (–6.792 to 7.452)
Role physical
Baseline 74.36 (69.62 to 79.09) 72.27 (67.41 to 77.14) 2.082 (–4.662 to 8.826)
12 months 73.45 (67.94 to 78.95) 72.84 (67.78 to 77.90) 0.605 (–6.820–8.029)
Bodily pain
Baseline 73.13 (69.09 to 77.17) 71.13 (67.48 to 74.78) 1.998 (–3.416 to 7.411)
12 months 72.93 (67.76 to 77.09) 69.31 (65.64 to 72.97) 3.621 (–1.891 to 9.132)
General health
Baseline 66.77 (63.29 to 70.25) 66.12 (62.71 to 69.54) 0.653 (–4.188 to 5.494)
12 months 70.42 (66.85 to 73.99) 68.66 (65.57 to 71.75) 1.763 (–2.924 to 6.449)
Vitality
Baseline 65.27 (62.80 to 67.74) 61.76 (58.99 to 64.53) 3.511 (–0.173 to 7.196)
12 months 65.53 (62.45 to 68.61) 60.49 (57.39 to 63.58) 5.041 (0.709 to 9.374) *
Social functioning
Baseline 78.77 (74.76 to 82.79) 74.26 (69.91 to 78.62) 4.512 (–1.377 to 10.401)
12 months 80.27 (76.24 to 84.29) 75.11 (70.66 to 79.56) 5.151 (–0.804 to 11.107)
Role emotional
Baseline 78.93 (74.32 to 85.53) 76.26 (71.48 to 79.62) 2.662 (–3.938 to 9.262)
12 months 80.52 (75.45 to 85.58) 74.52 (69.43 to 79.62) 5.995 (–1.138 to 13.129)
Mental health
Baseline 73.12 (70.63 to 75.61) 71.06 (67.74 to 74.37) 2.058 (–2.065 to 6.180)
12 months 75.12 (72.16 to 78.08) 71.53 (68.25 to 74.82) 3.586 (–0.806 to 7.979)
Physical component score
Baseline 49.57 (48.17 to 50.97) 48.80 (47.32 to 50.28) 0.772 (–1.249 to 2.793)
12 months 48.99 (47.51 to 50.47) 49.06 (47.79 to 50.32) –0.069 (–1.997 to 1.860)
Mental component score
Baseline 50.09 (48.71 to 51.46) 48.65 (46.82 to 50.48) 1.440 (–0.835 to 3.715)
12 months 51.34 (49.81 to 52.86) 48.39 (46.54 to 50.23) 2.951 (0.573 to 5.329) *

*Significant at p<0.05.

a

Determined with linear mixed effect.